Last reviewed · How we verify

Other progestin containing oral contraceptive

Center for Epidemiology and Health Research, Germany · Phase 2 active Small molecule

Other progestin containing oral contraceptive is a Small molecule drug developed by Center for Epidemiology and Health Research, Germany. It is currently in Phase 2 development.

At a glance

Generic nameOther progestin containing oral contraceptive
SponsorCenter for Epidemiology and Health Research, Germany
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Other progestin containing oral contraceptive

What is Other progestin containing oral contraceptive?

Other progestin containing oral contraceptive is a Small molecule drug developed by Center for Epidemiology and Health Research, Germany.

Who makes Other progestin containing oral contraceptive?

Other progestin containing oral contraceptive is developed by Center for Epidemiology and Health Research, Germany (see full Center for Epidemiology and Health Research, Germany pipeline at /company/center-for-epidemiology-and-health-research-germany).

What development phase is Other progestin containing oral contraceptive in?

Other progestin containing oral contraceptive is in Phase 2.

Related